Can Fite Biopharma Ltd (CANF) — Long-term Investment Intensity
Can Fite Biopharma Ltd (CANF) has a Long-term Investment Intensity of 9.9% as of September 2018. Long-term investments of ILA1.08 Million represent 9.9% of total assets of ILA10.82 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check Can Fite Biopharma Ltd liquid asset ratio to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Can Fite Biopharma Ltd Long-term Investment Intensity (2017–2017)
This chart shows how Can Fite Biopharma Ltd's Long-term Investment Intensity has evolved across 1 annual periods from 2017 to 2017. As of September 2018, the intensity stands at 9.9%, reflecting long-term investments of ILA1.08 Million against total assets of ILA10.82 Million ILA. For the complete balance sheet picture, see Can Fite Biopharma Ltd (CANF) total assets.
Annual Long-term Investment Intensity for Can Fite Biopharma Ltd (2017–2017)
The table below presents the year-by-year Long-term Investment Intensity for Can Fite Biopharma Ltd from 2017 to 2017, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read CANF total liabilities for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (ILA) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2017 | 11.7% | ILA914.66K | ILA7.83 Million | — |